Affidea, Europe’s leading diagnostic imaging provider, is investing in Ireland and today officially opened its first ExpressCare clinic in the Elysian building in Cork City. ExpressCare clinic in Cork will provide high quality treatment for patients with minor injuries and illnesses, offering an alternative to a traditional hospital setting.
Affidea Group, the leading European provider of diagnostic imaging and outpatient care services, announces that it has successfully completed the acquisition of Főnix-Med, an important Hungarian corporate healthcare and retail outpatient service provider.
Affidea Group, the leading Pan-European provider of diagnostic imaging and cancer treatment services, announces that, after receiving all necessary regulatory approvals, it has successfully completed the acquisition of a 100% stake in Q Diagnostica from Alantra Private Equity. With this, Affidea enters the Spanish market and reinforces its position in Europe.
Affidea Ireland is making good on its commitment to invest further in Irish diagnostic healthcare services and expand its reach by opening a new, multimodality greenfield centre in Letterkenny this month.
Whether it is the Rock n Roll Half Marathon (a global brand originating in the US), the World Medical Football Championships (what European Cup?) or Setúbal European Capital of Sport, Affidea is present as a major sponsor, deploying brand activation and supporting these huge, crowd-drawing sports events, as part of its commitment to promoting a healthy lifestyle and proactive approach to healthcare and prevention.
Affidea’s Chief Technology Officer Zisis Sotiriou was invited to be a keynote speaker at GE’s “Healthcare Europe’s Sales” conference held in Athens this month. The conference was attended by 350 invited guests, industry leaders from every business leg of the European healthcare market.
July saw the launch of the much talked-about Affidea Academy, with two separate educational events kicking it off – the MRI Prostate Training Course in Budapest and the first-of-its-kind international Medical Physics Radiotherapy Workshop in Poznan, bringing together medical physicists from every Polish CTC centre with the team from Bosnia.
On 25th June, Greece became the 13th country of operations to rebrand and join the Affidea family. In true Greek style, the summer event was held on a beautiful beach just outside Athens, with blue cocktails, fire-eaters and dance shows to usher in the new era of Affidea Greece.
Across Europe, Affidea is launching new initiatives developed at the spring Marketing Best Practices workshop in Warsaw, with the aim of increasing private revenues and spreading key company messages in line with the Affidea values.
Affidea Lietuva is expanding its predominantly MRI-based offering to include advanced CT services in Northern Lithuania, reaching out to a catchment area of half a million patients in the Šiauliai and Panėvežys counties in a move that will reduce waiting lists exponentially.
In 2016, for the first time, Affidea had its own, dedicated booth at ESTRO – the congress of the European Society for Radiotherapy and Oncology - this year held in Turin, Northern Italy. As part of the strategy to increase its presence on the cancer treatment and radiotherapy market, Affidea made its debut at ESTRO with a fully branded booth and a team of representatives engaging in high level networking talks and attracting new business.
Affidea is branching out in Northern Greece and adding a third centre to its collection in Kozani. In addition to the multimodality diagnostic and lab centres, there will now be a specialist cardiac CT centre, also performing private US examinations.
The second Friday of April was particularly long-awaited by Croatian staff, as headquarters invited the teams to a party to celebrate the rebranding of Croatian operations and the start of the new era of Affidea Croatia.
Affidea was honoured to welcome Mr Ernesto Bertarelli, the Chairman of Waypoint Capital, which manages our shareholder’s investment in our company, and his Board of Directors to Budapest this month.
The European Congress of Radiology is the key European event of the year for the radiology profession. With over 20,000 relevant professional participants, over 1,500 lectures and 2,700 posters presenting medical research findings, all in just 5 days, it is the biggest live platform for the industry, which makes up 78% of Affidea’s business.
Affidea Portugal has begun the process of rebranding by opening the very first centre designed according to new company guidelines, to be released later this year. The stunning pilot version of the ultra modern design has sparked interest throughout the local region in Portugal, as well as the wider Affidea network.
The Affidea diagnostic centre located in the Letia Technology Park in Legnica was recently opened to patients. The facility offers high-quality diagnostic tests in computed tomography (CT), magnetic resonance imaging (MRI) and ultrasonography, as well as X-ray examinations.
Each year, more than 17,000 new breast cancer cases are reported in Poland, leading to over 5,600 deaths, many of which are primarily due to late detection. But what does all this have to do with baking bread?
This interdisciplinary science project, launched in Affidea Polska’s Otwock Centre, explores the secrets of the unopened sarcophagus of an ancient Egyptian mummy and 41 other artefacts and has captured the imagination of thousands across Europe and the world.
The second Friday of December was particularly long-awaited by Italian staff as headquarters invited the teams to a massive party to celebrate the rebranding of Italian operations and the start of the new era of Affidea Italy.
The Heraklion Chamber of Commerce and Industry organised an event to present efficient management tools that can support companies in challenging environments to the local business community. Affidea was invited to present their lean management techniques and show how the lean journey has supported the performance of the company.
Affidea Polska has just announced its successful acquisition of the three specialist diagnostic centres NZOZ Diagnosis-Radom, NZOZ Radiologica-Rzeszów and NZOZ Diagnosis-Krosno. Thus the company has reinforced its position in Masovia and extended its coverage to the Subcarpathian region, where it has not been present up to now.
The Affidea Dose Excellence Campaign, launched back in March 2014 and since rolled out to seven countries of operation, will be published in the November issue of the medical journal HealthManagement.org.
The very latest Affidea centre has just opened in the Swiss city of Visp, near the existing Brig centre. The opening of the new Visp site marks an important occasion in the development of Swiss operations – it is Affidea’s first ever greenfield in Switzerland, all the preceding Swiss sites were acquisitions of existing centres.
The rebranding event in Turkey was attended by several members of Affidea’s top management, including Vice President CEE and CEO Turkey Mr Emir Aslan Özler and Vice President Strategy and Business Development Mrs Jasna Omeragic-Resic, as well as Brand Strategist Mr Peter Economides.
Affidea is proud to support the European School of Radiology annual Asklepios Multi-Modality Course aimed at radiologists, general practitioners and final year residents who wish to update their knowledge of new applications and optimise protocols in diagnostic imaging.
As of September 28th, Affidea is delighted to welcome its new Chief Medical Officer, Dr Rowland Illing. Dr Illing is a highly qualified radiologist with an extensive list of significant academic qualifications, all of which focus on radiology and diagnostic imaging.
Diagnoscan Hungary, member of the Affidea group and Hungary's largest provider of healthcare services, has expanded and renovated its fully private centre in the Mammut Shopping Mall in central Budapest.
On the 1st September, Affidea Romania announced its successful takeover of the Phoenix Group in the cities of Cluj-Napoca, Piatra Neamt, Deva and Medias, thus expanding its local market presence with 4 more diagnostic imaging centres.
From August 27-29th the International Society for Strategic Studies in Radiology held their eleventh biennial symposium in Amsterdam. The exclusive event, which is open only to academic and industry leaders, was attended by Affidea CEO Dimitris Moulavasilis, who was invited to make a presentation on Affidea’s Big Data Initiatives, in line with this year’s theme of Drugs, Bytes and Standards: The Future of Radiology.
As of August 2015, Romanian patients have access to one of the best, most precise and safest PET-CTs in Central and Eastern Europe, the Discovery IQ from GE, recently installed in the Affidea Fundeni Centre. Meanwhile, Affidea Romania completed its range of high-performance medical imaging services by installing the most advanced 1.5 Tesla MRI in the West of the country.
Banja Luka Centre for Radiotherapy, the first Affidea centre established in the Republic of Srpska and Bosnia and Herzegovina, has been providing services for oncology patients in the Republic of Srpska for five years this August.
As Switzerland joins the list of countries rebranded to Affidea in the corporate network, Group CEO, Dimitris Moulavasilis, and CEO of Affidea Switzerland, Ralph Hefti, give an interview to Tribune de Genève, detailing the company rebranding strategy, which goes hand in hand with its ambitious expansion plans.
On the 26th June Affidea Switzerland became the fifth country to rebrand its operations. The occasion was marked by an elegant, low key event and dinner at the Swatch group’s “La Cité du Temps” events’ centre in the heart of Geneva.
Cancer study in 4-5 minutes instead of 20? Imaging/detecting changes of 2-3mm? Yes, it is possible thanks to the ultramodern PET-CT scanner, which became operational in Affidea Poznań as of June 24th.
Diagnoscan Magyarország, Member of the Affidea Group, has opened its third fully private centre in the capital city of Budapest this June. Following the success of its Mammut and Bank Center clinics, the country’s largest diagnostic imaging specialist has continued to focus its growth on the private market.
The rebranding event in Romania was attended by several members of Affidea’s top management, including Group CEO Dimitris Moulavasilis, CFO Bence Várady-Szabó, Vice President CEE Mr Emir Aslan Özler as well as Director of Affidea shareholder Waypoint Capital, Mr Richard Broyd.
As a three and a half year affiliation draws to an end, the Houston Methodist and Affidea teams met in Istanbul from 25 to 27 May at their 5th Workshop to conclude current evidence-based treatment protocols and recapitulate the main achievements of the affiliation.
This month Affidea Greece is opening an entirely new centre in inner city Athens. The Dafni Diagnostic Centre is located opposite a busy metro station, just a stone’s throw from the bustling city centre and will perform ultrasound and laboratory examinations, primarily for the members of a small PHI, private health insurance group, whilst also being open to other private patients.
On May 22nd in Portugal, approximately 30,000 women took up the fight against breast cancer by running or walking 5km in Lisbon and Oporto. These two cities showed an equal commitment to this important cause, with about 15,000 all-female participants in each.
This year, for the eighth time, the Business Superbrands jury, currently consisting of 18 independent expert members, met to decide which brands would receive Business Superbrands recognition, based on the Bisnode professional database.
Affidea's operations in Ireland (yet to rebrand) have successfully completed the acquisition of the business of Vista Medical Imaging Naas Co. Kildare. With the acquisition of the business of Vista Medical Imaging, Affidea has further strengthened its No 1 position for private diagnostic scanning in the Irish market.
Tomotherapy is the newest addition to Affidea’s state-of-the-art Baskent University Centre in Adana, Southern Turkey. The centre, which already operates the latest oncological technology, i.e. high end Linear Accelerators and the Gamma Knife, has now expanded to provide a unique range of cancer treatment services in the region.
The European Congress of Radiology, the biggest event of the year for the European radiology society, was held in Vienna between March 4-8th and attracted over 20,000 participants from the industry and related fields.
On 4th February 2015, Affidea successfully completed the acquisition of Ve.Di Gruppo Sanitario, one of the largest private healthcare providers in Northern Italy, specialising in diagnostic imaging, laboratory and outpatient medical services.
London, 16th December, 2014: Waypoint Capital (“Waypoint”) and Euromedic International (“Euromedic” or “the Company”) have received competition clearance from the Turkish and Polish authorities allowing for the completion of the recent transaction which will see Waypoint take full responsibility for Euromedic.
Ozone therapy is the initiative that has recently been introduced in Euromedic Czech Republic’s Mediscan Centre. The method uses the naturally occurring O3 gas (three molecules of oxygen or OO2) to treat a whole range of conditions, from slipped disks to asthma, due to its anti-inflammatory and painkilling effects
The Fourth EMI-HM Workshop was held in Wroclaw, Poland, from 13-15th October. Prof. Brian Butler from The Methodist Hospital (TMH) in Houston together with his team of radiotherapy experts, yet again worked with Euromedic specialists from Poland and Bosnia on developing cancer treatment standards – this time, focusing on lung and prostate cancers.
Montagu Private Equity LLP (“Montagu”), one of Europe’s longest established private equity firms, today announced the sale of its holding in Euromedic International (“Euromedic” or “the Company”), the largest pan-European medical services provider, to Ares Life Sciences (“Ares”), an investment partnership of Waypoint Capital and the current majority owner of the Company. Terms of the transaction were not disclosed. The transaction is expected to complete in 2014, subject to customary regulatory approvals.
London, 30 September, 2014: Waypoint Capital ("Waypoint") and Montagu Private Equity ("Montagu") have agreed terms for Montagu to sell its entire holding in Euromedic International ("Euromedic" or "the Company") to Waypoint. Through its investment partnership, Ares Life Sciences, Waypoint is already the majority investor in Euromedic and will now assume full ownership.